Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 98.5965
Recommendation STRONG BUY
P/E 2.32
ROE 21.98 %
Capitalization 354,912,180 $
Dividend Yield 27.65 %
P/S 0.60
AII Position 40
P/E Position 2
ROE Position 141
Capitalization Position 777
Dividend Yield Position 2
Sales 590,448,000 $
10-Year Average Earnings 152,946,700 $
Shares Outstanding 163,554,000
Equity 695,952,000 $
Dividend per Share 0.6 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $
2008 12 68,387,000.00 $
2007 12 -21,061,000.00 $
2006 12 -130,020,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
283 64,685 PDII PDI INC 37,088 35,330 10,856 PDLI PDL BIOPHARMA IN 15,552,112 15,369,417 2,425,494 PGC PEAPACK GLADSTON...
May 4, 2012
Midmorning Positive EPS Surprises for U.S. Companies, May 4
-73.5 0.11 18.2 Mar GEOY GEOEYE INC 0.58 0.44 31.8 0.50 16.0 Mar PDLI PDL BIOPHARMA IN 0.30 0.25 20.0 0.26 15.4 Mar TICKER ...
Jul 28, 2011
Midmorning Positive EPS Surprises for U.S. Companies, July 28
7.5 0.43 0.0 Jun HUBG HUB GROUP-A 0.39 0.26 50.0 0.39 0.0 Jun PDLI PDL BIOPHARMA IN 0.39 0.38 2.6 0.39 0.0 Jun FISI FINANCIAL INST ...
Nov 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Nov. 9
-1.82 -4.31 ASH# ASHLAND INC 1.01 1.05 -3.8 0.93 8.6 -5.16 -9.35 PDLI# PDL BIOPHARMA IN 0.28 0.24 16.7 0.26 7.7 -0.19 -3.10 ENS# ENERSYS ...
Jun 22, 2007
Stocks: Eleven Cash-Flow Champs
12.14 PDL Biopharma (PDLI) 24.02 ...
Jun 13, 2008
Benihana, Knot, Steel Dynamics: U.S. Equity Movers
develops protein drugs said Amgen Inc. (AMGN US) may sue for patent infringement. PDL Biopharma Inc. (PDLI US) lost the most since May 6, falling 3.3 percent to $10.75. The developer of technology to make...
Aug 20, 2008
McClatchy, Novatel, PDL BioPharma: U.S. Small-Cap Equity Movers
Analysts expected 14 cents, based on the average estimate in a Bloomberg survey. PDL BioPharma Inc. (PDLI US) rose the most in four months, advancing 5.4 percent to $12.44. Bristol-Myers Squibb Co. (BMY...
Apr 11, 2008
Lights Out for Stocks after GE News
at Thomas Weisel have reportedly downgraded the stock to "market weight." PDL BioPharma (PDLI) plans to pay out a special cash dividend of $4.25 per share, and spin off its biotech assets...
Mar 5, 2008
Analyst Actions: BJ's Wholesale Club, Chico's FAS, PDL Biopharma
DOWNGRADES PDL BIOPHARMA Lehman Brothers analyst Jim Birchenough says he cuts PDL Biopharma (PDLI) shares to equal-weight from overweight following the end of the company's strategic review. ...
Aug 13, 2010
Comverse, Electromed, Premier, Telestone: U.S. Equity Movers
the current quarter to increase as much as 5 percent from the prior period. PDL BioPharma Inc. (PDLI US) dropped the most in Russell 2000 Index, sliding 16 percent to $5.20. The developer of antibodies...


Google News for PDL BIOPHARMA:

StockNewsJournal - 1 day ago
Buy or Sell? Average Brokerage Ratings on PDL BioPharma, Inc ...
PDL BioPharma, Inc. (NASDAQ:PDLI) gained 1.18% with the closing price of $2.57. The overall volume in the last trading session was 1.61 ...
Sports Perspectives
Another motive To buy these stock: PDL BioPharma, Inc. (PDLI ...
PDL BioPharma, Inc. (NASDAQ:PDLI) market capitalization at present is $405.28M at the rate of $2.54 a share. The firm's price-to-sales ratio ...
Weekly Register
PDL BioPharma, Inc. (NasdaqGS:PDLI) Shareholder Yield in Focus
The Current Ratio of PDL BioPharma, Inc. (NasdaqGS:PDLI) is 1.98. The Current Ratio is used by investors to determine whether a company ...
The Cerbat Gem
PDL BioPharma, Inc. (PDLI): From Top to Bottom
PDL BioPharma, Inc. (PDLI) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the ...
StockNewsJournal - 2 days ago
PDL BioPharma Inc (PDLI) Ichimoku Reveals Positive Momentum
Shares of PDL BioPharma Inc (PDLI) opened the last session at $2.48, touching a high of $2.60 and a low of $2.43 , yielding a change of 0.08.
USA Commerce Daily
Sales Growth Analysis: PDL BioPharma, Inc. (PDLI), Tempur Sealy ...
Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) are on a recovery track as they have regained 33.16% since bottoming out at $1.93 on Dec.
Sports Perspectives
Which Way Traders Signposts PDL BioPharma, Inc. (PDLI ...
PDL BioPharma, Inc. (NASDAQ:PDLI) gained 0.88% with the closing price of $2.29. The overall volume in the last trading session was 2.44 ...
The Cerbat Gem
Critical Chart Information For PDL BioPharma, Inc. (PDLI)
The technicals for PDL BioPharma, Inc. (PDLI) have taken shape, and with them a comprehensive picture has emerged. This is the current state ...
Financial Newsweek - 14 hours ago
Notable movements of Stock: PDL BioPharma, Inc. (PDLI)
In Healthcare sector, shares of PDL BioPharma, Inc. (PDLI) were valued at $2.50 and moved -2.72% as of a recent closing trade. A total volume ...
StockNewsJournal - 5 days ago
Checking the Overall Picture for PDL BioPharma, Inc. (PDLI)
PDL BioPharma, Inc. (PDLI) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the ...


Back